On July 2, 2024, Hutchmed (China) Limited submitted the latest monthly report of securities changes to Hong Kong Exchanges and Clearing Limited, covering the situation as of June 30, 2024. The report shows that the company's statutory/registered capital remained at US$1.5 billion, with a par value of US$0.1 per share, totaling US$150 million, and there were no changes this month. The number of issued shares (excluding treasury shares) increased from 871,264,820 shares last month to 871,359,720 shares, an increase of 94,900 shares. These new shares are from the stock option plan passed on April 24, 2015. This month, 94,900 stock options were exercised, while 168,750 stock options expired, reducing the total number of options from 29,567,691 shares to 29,304,041 shares. The report confirms that all changes in securities issuance or treasury shares have been authorized by the board of directors and comply with relevant listing rules and legal requirements.

On July 2, 2024, Hutchmed (China) Limited submitted the latest monthly report of securities changes to Hong Kong Exchanges and Clearing Limited, covering the situation as of June 30, 2024. The report shows that the company's statutory/registered capital remained at US$1.5 billion, with a par value of US$0.1 per share, totaling US$150 million, and there were no changes this month. The number of issued shares (excluding treasury shares) increased from 871,264,820 shares last month to 871,359,720 shares, an increase of 94,900 shares. These new shares are from the stock option plan passed on April 24, 2015. This month, 94,900 stock options were exercised, while 168,750 stock options expired, reducing the total number of options from 29,567,691 shares to 29,304,041 shares. The report confirms that all changes in securities issuance or treasury shares have been authorized by the board of directors and comply with relevant listing rules and legal requirements.